Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 6, 2024; 12(19): 3791-3799
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3791
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3791
Table 2 Pathological results of lung puncture biopsy of contrast-enhanced ultrasound group and control group, n (%)
| CEUS group | Control group | χ2 value | P value | |
| Confirmed cases | 113 (95.8) | 107 (89.9) | 3.042 | 0.081 |
| Undiagnostic biopsy | 5 (4.2) | 12 (10.1) | ||
| Pathology results | 7.93 | 0.541 | ||
| Adenocarcinoma | 60 (50.8) | 52 (43.6) | ||
| Squamous cell carcinoma | 26 (22.0) | 19 (16.1) | ||
| Small cell carcinoma | 4 (3.4) | 4 (3.4) | ||
| Metastatic cancer | 5 (4.2) | 7 (5.9) | ||
| Pneumonia | 10 (8.5) | 13 (10.9) | ||
| Tuberculosis | 1 (0.8) | 0 (0) | ||
| Pulmonary fibrosis | 2 (1.7) | 4 (3.4) | ||
| Normal | 2 (1.7) | 2 (1.7) | ||
| Others | 3 (2.5) | 6 (5.0) |
- Citation: Jiang X, Chen J, Gu FF, Li ZR, Song YS, Long JJ, Zhang SZ, Xu TT, Tang YJ, Gu JY, Fang XM. Evaluating the efficacy of percutaneous puncture biopsy guided by contrast-enhanced ultrasound for peripheral pulmonary lesions. World J Clin Cases 2024; 12(19): 3791-3799
- URL: https://www.wjgnet.com/2307-8960/full/v12/i19/3791.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i19.3791